Objectives
Objectives for Section 1: Peripheral IV Therapy
Upon completion of this curriculum, the nurse will be able to:
- List specific measures that will protect against malpractice.
- Identify infusion related complications, causes and appropriate treatment.
- Demonstrate the correct calculation of an IV flow rate.
- Identify methods of infection control related to IV therapy.
- List the components of accurate and complete documentation of IV procedures and complications.
- Demonstrate IV and Infusion related procedures.
Objectives for Section 2: Central Venous Access Devices (CVAD)
Upon completion of this curriculum, the nurse will be able to:
- Describe protective measures to guard against malpractice suits.
- List 3 reasons for use and advantages of central lines.
- List 4 veins used for central venous device placement and proper tip position.
- Identify the various types of central lines.
- Identify symptoms and prevention of complications.
- Describe assessment criteria and documentation required for patients with central venous catheters.
Objectives for Section 4: Hypodermoclysis (Clysis)
Upon completion of this curriculum, the nurse will be able to:
- Identify at least three negative effects of central line related bloodstream infections.
- Identify at least two methods by which central lines become colonized.
- Identify at least three strategies to reduce the risk of CRBSI at the time of catheter insertion.
- Recognize the proper time intervals and procedures for dressing change, injection port change, and site observation.
- State the recommended methods for obtaining blood cultures for CRBSI diagnosis.
- State the recommended methods for treating CRBSI.
Objectives for Section 5: Total Parenteral Nutrition (TPN)
Upon completion of this curriculum, the nurse will be able to:
- Identify at least three medical conditions that indicate the use of TPN.
- Identify at least three components of TPN.
- Demonstrate understanding of TPN administration by recognizing the steps involved in TPN preparation and infusion.
- Recognize at least two potential complications of TPN.
- State at least four TPN monitoring measurements.
Objectives for Section 6: Transfusion Therapies
Upon completion of this curriculum, the nurse will be able to:
- Explain the blood grouping systems and their importance in transfusion therapy.
- List available blood components and indications for each.
- Describe the activities required in preparation for a transfusion.
- Identify equipment used to administer a transfusion and it’s proper usage.
- Describe the nursing management of a blood component infusion.
- Describe signs and symptoms of transfusion reactions, and appropriate interventions for each.
- Explain appropriate patient education related to transfusion therapy.
- Identify the required documentation for a blood transfusion.
Objectives for Section 7: Chemotherapy
Upon completion of this curriculum, the nurse will be able to:
- Define how chemotherapy is used in cancer management.
- List the major chemotherapy drug classifications and their general mechanisms of action.
- Identify the major side effects/toxicities of chemotherapeutic agents.
- Describe safe chemotherapy handling techniques.
- Describe appropriate chemotherapy administration.
- Recognize common psychological effects in patients receiving chemotherapy.
Objectives for Section 8: Gamma Globulin (IgG)
Upon completion of this curriculum, the nurse will be able to:
- Name at least three conditions for which gamma globulin is indicated.
- Demonstrate understanding of gamma globulin administration by recognizing the steps involved in its preparation and infusion.
- Recognize at least two side effects of gamma globulin infusion.
Curriculum
Chapter 1: Legal Issues
- Regulatory Agencies and Governing Bodies
- Components of a Complete Physicians Order
- Legal Terms and Applications in Nursing
- Protective Measures for Guarding against Malpractice Lawsuits
- Rules specific to the Florida
Chapter 2: Anatomy and Physiology
- The Vascular System: Veins, Arteries and Bone Marrow
- The Three Layers of the Vessels and Their Function
- Differentiating Arteries from Veins
- Veins used in Peripheral Intravenous Therapy for Pediatrics and Adults
- Intraosseous
- Skin: Anatomy and Physiology
Chapter 3: Psychological Needs
- Age Specific Needs of Children
- Elderly Patient Needs
- Cultural Aspects
- Patients with Sensory Deficits
- Methods of Reducing Patient Anxiety
- Patient Teaching/Education
Chapter 4: Fluid and Electrolyte Balance
- Water: The Primary Fluid of the Body
- Hypovolemia—Dehydration: Assessment, Causes, Treatments
- Hypervolemia—Fluid Overload: Assessment, Causes, Treatments
- Fluid Compartments
- Electrolyte Imbalances: Assessment, Causes, Treatments
Chapter 5: pH, Tonicity, Compatibility
- pH of Intravenous Solutions and Medications
- Tonicity: Isotonic solutions, Hypotonic solutions and Hypertonic Solutions Incompatibilities
Chapter 6: Fluid Regulation
- Methods of Fluid Regulation
- Patient Considerations in Fluid Regulation
- External Factors that Affect the Rate of Flow
- Calculation of IV flow rates
Chapter 7: Infection Prevention and Safety Compliance
- Hand Hygiene
- Sharps Management
- Medical Waste Disposal
- Durable Medical Equipment Disinfection
- Standard Precautions
- Transmission-Based Precautions
Chapter 8: Vascular Visualization
- Trans-illuminator Technology
- Near Infrared Technology
- Ultrasound
Chapter 9: Peripheral IV Site Selection and Placement
- Criteria For Peripheral Devices
- 3 Types Of Peripheral Access And Criteria For Placement
- Special Considerations Of The Specific Age Groups
- General Considerations Of Short Peripheral Access
- Veins To Avoid
Chapter 10: Peripheral VAD Management
- Needleless Connectors
- Filtration
- Add-on Devices
- VAD Stabilization
- Joint Stabilization
- Site Protection
- Flushing and Locking
- Assessment, Care, and Dressing Changes
- Administration Set Changes
Chapter 11: Peripheral IV Guides and Videos
- Pre-insertion Procedures
- Peripheral IV Insertion
- Primary and Secondary Administration set-up
- IV Push Administration
- Catheter Discontinuation
Chapter 12: Peripheral IV Assessment and Documentation
- Catheter Insertion Documentation
- Catheter Removal Documentation
- Assessment, Monitoring and Documentation by Therapy
Chapter 13: Central Line Review
- Definition of a Central Line:
- Reasons for Use
- Advantages
- Overview of Central Venous Access Devices:
- Lumens
- Non‐valved and Valved Catheters
- Non‐tunneled Catheters
- Tunneled Catheters
- Implanted Ports
- PICC or Peripherally Inserted Central Catheter
Chapter 14: Anatomy
- Veins Used for Placement
- Catheter Tip Placement
Chapter 15: Assessment and Preparations for Central Venous Catheterization
- Considerations for the Selection of the Device
- Preparations for Central Venous Catheterization
Chapter 16: Vascular Access Device Management
- Needleless Connectors
- CVAD Stabilization
- Site Protection
- Flushing and Locking
- Assessment, Care, and Dressing Changes
- Administration Set Changes
- Blood Sampling from a CVAD
Chapter 17: Complications
- Catheter-related Complications
- Systemic Complications
- Insertion-related Complications
Chapter 18: Discontinuation of Therapy
- Removal of Devices
- CVAD Removal Procedure
Chapter 19: Assessment, Documentation, and Patient Education
- Documentation of Insertion, Removal, Infiltration, or Extravasations
- Assessment, Monitoring, and Documentation
Chapter 20: Scope of Problem
- Morbidity / Mortality
- Cost
- Surveillance
Chapter 21: Catheter Insertion
- Site Selection
- Sterile Technique
- Antimicrobial Impregnated Catheters
Chapter 22: Catheter Site Maintenance
- Dressing
- Needleless Connector
- Observation
Chapter 23: Medication Administration
- Infusate
- Administration Set
- Flushing
Chapter 24: Diagnosis and Treatment
- Clinical Findings
- Cultures
- Treatment
Chapter 25: Dehydration
- Scope of Problem
- Contributing Factors
- Signs and Symptoms
- Assessment
Chapter 26: Hypodermoclysis Introduction
- Advantages
- Disadvantage
- Indications
- Contraindications
- Use in Terminally Ill Patients
Chapter 27: Infusion Parameters
- Sites
- Solutions
- Volume and Rate
- Hyaluronidase
Chapter 28: Administration
Chapter 29: Complications
- Systemic Complications
- Local Complications
Chapter 30: Communication and Documentation
Chapter 31: Indications for Parenteral Nutrition
- Altered Absorption Capacity
- GI Disorders Requiring Complete Bowel Rest
- Intractable Vomiting or Diarrhea
- Hypermetabolic States
- Anorexia Nervosa
Chapter 32: TPN Goals
- Maintenance of Normal Body Weight and Protein Status
- Restoration of Normal Body Weight and Protein Status
- Maintenance or Restoration of Normal Micronutritional Status
Chapter 33: Normal Nutritional Requirements
- Protein
- Carbohydrate
- Lipid
- Vitamins
- Minerals
- Trace Elements
Chapter 34: Nutritional Assessment
- Anthropometrics
- Biochemical
- Clinical
- Dietary
Chapter 35: Composition of Parenteral Nutrition
- Dextrose
- Amino Acids
- Lipids
- Water
- Electrolytes
- Vitamins
- Trace Elements
- Other Additives
Chapter 36: TPN Administration
- Central Venous Access Devices
- Electronic Infusion Devices
- TPN and Lipids
- Preparing the TPN for Infusion
- Initiating the Infusion
Chapter 37: TPN Complications
- Metabolic Complications
- Vascular Access Device-Related Complications
Chapter 38: Monitoring and Documentation
- Vital Signs
- Glucose
- Weight
- Intake and Output
- Laboratory Values
- TPN Administration
- IV Catheter Care
Chapter 31: Introduction to Transfusion Therapy
- Blood Components
- ABO Blood Group System
- Rh Blood Group System
- Other Blood Group Antigens
- HLA System
Chapter 32: Whole Blood
Chapter 33: Packed Red Blood Cells
- Description
- Indications
- Donation and Testing
- Red Blood Cell Subsets
Chapter 34: Platelets
- Description
- Indications
- Donation and Testing
- Platelet Subsets
Chapter 35: Plasma
- Description
- Indications
- Donation and Testing
Chapter 36: Granulocytes
- Description
- Indications
- Donation and Testing
Chapter 37: Clotting Factors
- Cryoprecipitate
- Factor Concentrates
Chapter 38: Pre-transfusion Activities
- Licensed Independent Prescriber Order
- Patient Consent
- Type and Crossmatch
- Vascular Access
- Baseline Vital Signs
Chapter 39: Administration
- Component Transport and Storage
- Equipment
- Pre-medication
- Identification
- Administration
- Monitoring
- Patient Education
- Documentation
Chapter 40: Complications
- Immune Complications
- Hemolytic Reactions
- Non-Hemolytic Reactions
- Non-immune Complications
- Infectious Complications
- Transfusion Associated Fluid Overload (TACO)
- Complications of Massive Transfusion
Chapter 49: Introduction to Chemotherapy
- Definition
- Goals of Chemotherapy
- Cell Cycle
- Chemotherapy Approaches
Chapter 50: Chemotherapy Drug Classifications
- Cell-cycle Specificity
- Mechanism of Action
- Alkylating Agents
- Antimetabolites
- Antitumor Antibiotics
- Histone Deacetylase Inhibitors
- Mitotic Inhibitors
- Proteasome Inhibitors
- Topoisomerase Inhibitors
- Miscellaneous
- Cytoprotective Agents
- Uricolytic Agents
- Biphosphonates
- Pyrimidine Analogs
- Growth Factors
- Trilaciclib
Chapter 51: Chemotherapy Side Effects
- Myelosuppression
- Gastrointestinal
- Integumentary
- Cardiovascular
- Respiratory
- Renal
- Neurologic
- Reproductive
Chapter 52: Safe Handling
- USP <800>
- Preparation
- Administration
- Disposal
- Bodily Discharges
Chapter 53: Administration
- Pre-administration Activities
- Routes of Administration
Chapter 54: Psychological Effects
- Grief
- Loss of Status
- Desirability
- Long-term Concerns
Chapter 55: Introduction to Gamma Globulin
- Definition
- Indications
- Products
Chapter 56: Administration
Chapter 57: Possible Adverse Events
- Common Side Effect
- Uncommon Side Effects
- Anaphylaxis
Chapter 58: Patient Education
- Nurse Administration
- Patient Administration
Chapter 59: Assessment and Documentation
Chapter 60: Skill Checklists
Chapter 61: References